EUCAST News

04 May 2022

Consultation on the availability of piperacillin and ticarcillin without inhibitors.

EUCAST is considering removing breakpoints for piperacillin without tazobactam and/or ticarcillin without clavulanic acid but only if these agents are no longer used. 
If you in your country are still using either or both of these agents without an inhibitor, please inform the EUCAST Scientific Secratary John Turnidge,